Hyperuricemia
Hyperuricemia
Explore linked clinical trials. Standard reference: MESH:M040280441 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of the Effect of Allopurinol Versus Febuxostat on Serum Uric Acid in Patients With Chronic Kidney Disease Associated With Hyperuricemia | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperuricemia, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not applicable | 2026-09-30 | NCT07850713 | |
| A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07280156 | |
| A Study of Dotinurad Versus Allopurinol in Tophaceous Gout | Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 3 | 2026-09-28 | NCT07089888 | |
| A Study of Dotinurad Versus Allopurinol in Participants With Gout | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 3 | 2026-09-28 | NCT07089875 | |
| Mazdutide for Weight Management and Gout in Adults With Obesity | Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, arthritic joint disease, arthropathy, glucose metabolism disease, gout, hereditary disease, hyperinsulinism, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, nutritional disorder, obesity disorder, overnutrition, rheumatic disorder | Not yet recruiting | Phase 4 | 2026-09-17 | NCT07824895 | |
| Long-Term Risk of Gout in Living Kidney Donors | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Active, not recruiting | Not stated | 2026-09-14 | NCT07546643 | |
| SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 4 | 2026-08-05 | NCT06674109 | |
| A Study of IN026 in Participants With Refractory Gout | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, connective tissue disorder, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 1 | 2026-07-31 | NCT07587684 | |
| Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss | Alveolar Bone Loss, Hyperuricemia, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Periodontal Atrophy, Stomatognathic Diseases, bone disorder, bone resorption disease, mouth disorder, musculoskeletal system disorder, periodontal disorder | Recruiting | Not stated | 2026-06-26 | NCT07666126 | |
| Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia | Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not applicable | 2026-06-17 | NCT07613138 | |
| Probiotic-Uricase Complex Preparation for Improving Uric Acid Metabolism in Patients With Hyperuricemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Not applicable | 2026-05-29 | NCT07613164 | |
| Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients | Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Active, not recruiting | Phase 2 | 2026-05-15 | NCT07116746 | |
| The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia | Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 2 | 2026-04-07 | NCT07362355 | |
| Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Phase 2 | 2026-03-27 | NCT07498647 | |
| Chronic Kidney Disease and Metabolic Disorders in the Elderly | Chronic Disease, Disease Attributes, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperuricemia, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, urinary system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-03-27 | NCT07494526 | |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | Arthralgia, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Inflammation, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 2 / Phase 3 | 2026-03-11 | NCT05658575 | |
| Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia) | Dyslipidemias, Hyperuricemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, glucose metabolism disease, hyperglycemia, hyperlipidemia, hypertensive disorder, metabolic disease, vascular disorder | Recruiting | Not applicable | 2026-02-10 | NCT07400549 | |
| Treat-to-target by Email During Urate-lowering Therapy in Gout | Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, bacterial infectious disease, connective tissue disorder, gout, gram-positive bacterial infections, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder, rheumatic fever, streptococcal infection | Active, not recruiting | Not applicable | 2026-02-04 | NCT04733079 | |
| A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperuricemia, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, hereditary renal hypouricemia, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-02-03 | NCT06310967 | |
| HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness | Arthritis, Gouty, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, arthritic joint disease, arthropathy, dermatitis, drug allergy, erythema multiforme, gout, hereditary disease, immune system disorder, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, mouth disorder, musculoskeletal system disorder, rheumatic disorder, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 4 | 2026-01-27 | NCT07369622 | |
| Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy Subjects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Not applicable | 2026-01-26 | NCT07366749 | |
| Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) | Hyperuricemia, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Not yet recruiting | Not stated | 2026-01-13 | NCT07053709 | |
| Effect of Dotinurad in Hyperuricemia With Hypertension | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, cardiovascular disorder, gout, hereditary disease, hypertensive disorder, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder, vascular disorder | Recruiting | Phase 4 | 2025-12-15 | NCT06834230 | |
| Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) | Albuminuria, Body Weight, Cardiomegaly, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypertrophy, Hypertrophy, Left Ventricular, Hyperuricemia, Left Ventricular Diastolic Dysfunction, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, Ventricular Dysfunction, Ventricular Dysfunction, Left, autonomic nervous system disorder, cardiovascular disorder, heart disorder, hypertensive disorder, kidney disorder, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, primary dysautonomia, proteinuria, urinary system disorder, vascular disorder | Recruiting | Not stated | 2025-12-11 | NCT04752293 | |
| Hyperuricemia as Early Indication of CKD Progressing in Prediabetic | Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, prediabetes syndrome | Not yet recruiting | Not stated | 2025-09-30 | NCT07199205 |